Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Excellent Outcomes in Children and Young Adults Using Reduced-Intensity Conditioning for Patients with Inborn Errors of Immunity, Hematopoiesis, and Metabolism with Single-Unit Cord Blood or Bone Marrow

Mark Vander Lugt, MD, Hey Jin Chong, MD PhD, Xiaohua Chen, MDPhD, Randy M. Windreich, MD, Rakesh Goyal, MD MRCP, Maria Escolar, MD, Paul Szabolcs, MD

Blood (2015) 126 (23): 4329.

https://doi.org/10.1182/blood.V126.23.4329.4329

Published: 2015

Journal Articles

A Pilot Study Of Continuous Infusion Mycophenolate Mofetil For Graft Versus Host Disease Prophylaxis

Randy M. Windreich, MD, Rujuta Joshi, BS, Raman Venkataramanan, PhD, Denise Howrie, PharmD, Rakesh Goyal, MD, MRCP

Blood (2013) 122 (21): 4571.

https://doi.org/10.1182/blood.V122.21.4571.4571

Published: 2013

Journal Articles

The Relationship of Acute Gvhd and Pre- and Post-Transplant Flow-MRD to the Incidence and Timing of Relapse in Children Undergoing Allogeneic Transplantation for High Risk ALL: Defining a Target Population and Window for Immunological Intervention to Prevent Relapse

Michael A. Pulsipher, MD, Bryan Langholz, PhD, Donna A. Wall, MD, Kirk R. Schultz, MD, Nancy Bunin, MD, Julie M. Gastier-Foster, PhD, Michael J. Borowitz, MD, PhD, Rakesh Goyal, MD, MRCP, Sharon Gardner, MD, William L. Carroll, MD, Elizabeth Raetz, MD, Stephan A. Grupp, MD, PhD

Blood (2012) 120 (21): 470.

https://doi.org/10.1182/blood.V120.21.470.470

Published: 2012

Journal Articles

A Randomized Trial of Sirolimus-Based Graft Versus Host Disease (GVHD) Prophylaxis After Hematopoietic Stem Cell Transplantation (HSCT) in Selected Patients with CR1 and CR2 ALL: Results From Children's Oncology Group Study ASCT0431

Michael A. Pulsipher, MD, Bryan Langholz, PhD, Donna A. Wall, MD, Kirk R. Schultz, MD, Nancy Bunin, MD, William L. Carroll, MD, Elizabeth A. Raetz, MD, Sharon Gardner, MD, Julie M. Gastier-Foster, PhD, Denise Howrie, PharmD, Rakesh Goyal, MD, MRCP, Douglas James, MD, MRCP, Michael J. Borowitz, MD, PhD, Yvonne Jean Barnes, RN MSN CPNP, Shivanand R. Patil, PhD, David T Teachey, MD, Candace Taylor, CCRP, Stephan A Grupp, MD, PhD

Blood (2011) 118 (21): 837.

https://doi.org/10.1182/blood.V118.21.837.837

Published: 2011

Journal Articles

Safety and Efficacy of Hematopoietic Stem Cell Remobilization with Plerixafor (Mozobil ® ) + G-CSF In Pediatric Patients with Malignant Disorders

Shalini Shenoy, MD, Barbara Asselin, Jignesh Dalal, Rakesh Goyal, Jonathan L. Kaufman, MD, David Loeb, John McCarty, Kent Robertson, Caron Strahlendorf, Mark C. Walters, MD, Jennifer Angell, Dirk Huebner, MD, Peter J. Shaw, MA, MB, BS, MRCP, FRACP

Blood (2010) 116 (21): 2245.

https://doi.org/10.1182/blood.V116.21.2245.2245

Published: 2010

Journal Articles

Successful Engraftment Using Varied Stem Cell Sources, Low Toxicity, and Long-Term Survival Using a Bu/Flu/ATG Reduced Intensity Allogeneic Transplantation in High Risk Pediatric Patients Ineligible for Myelablative Therapy: Results of the Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study ONC0313.

Michael A. Pulsipher, Haydar Frangoul, Michel Duval, Rakesh Goyal, Peter J. Shaw, Ann Haight, Richard Kadota, Michael Grimley, Stephan A. Grupp, Morris Kletzel

Blood (2007) 110 (11): 623.

https://doi.org/10.1182/blood.V110.11.623.623

Published: 2007

Journal Articles

Low Rates of Toxicity, GVHD, and Relapse Using Sirolimus (SRL)-Based GVHD Prophylaxis in Pediatric Related and Unrelated Transplant Recipients with High-Risk ALL.

Michael Pulsipher, Donna Wall, Stephan Grupp, Rakesh Goyal, Nancy Bunin

Blood (2006) 108 (11): 2876.

https://doi.org/10.1182/blood.V108.11.2876.2876

Published: 2006

Journal Articles

Tacrolimus Versus Cyclosporine for Graft-Versus-Host Disease Prophylaxis in Pediatric Patients Undergoing Matched Unrelated Donor Hematopoietic Stem Cell Transplants. A Pediatric Blood and Marrow Transplant Consortium Study. .

Mark P. Atlas, MD, Gregory Yanik, MD, Rakesh Goyal, MD

Blood (2006) 108 (11): 2883.

https://doi.org/10.1182/blood.V108.11.2883.2883

Published: 2006

NARROW

Excellent Outcomes in Children and Young Adults Using Reduced-Intensity Conditioning for Patients with Inborn Errors of Immunity, Hematopoiesis, and Metabolism with Single-Unit Cord Blood or Bone Marrow

A Pilot Study Of Continuous Infusion Mycophenolate Mofetil For Graft Versus Host Disease Prophylaxis

The Relationship of Acute Gvhd and Pre- and Post-Transplant Flow-MRD to the Incidence and Timing of Relapse in Children Undergoing Allogeneic Transplantation for High Risk ALL: Defining a Target Population and Window for Immunological Intervention to Prevent Relapse

A Randomized Trial of Sirolimus-Based Graft Versus Host Disease (GVHD) Prophylaxis After Hematopoietic Stem Cell Transplantation (HSCT) in Selected Patients with CR1 and CR2 ALL: Results From Children's Oncology Group Study ASCT0431

Safety and Efficacy of Hematopoietic Stem Cell Remobilization with Plerixafor (Mozobil ® ) + G-CSF In Pediatric Patients with Malignant Disorders

Low Rates of Toxicity, GVHD, and Relapse Using Sirolimus (SRL)-Based GVHD Prophylaxis in Pediatric Related and Unrelated Transplant Recipients with High-Risk ALL.

Tacrolimus Versus Cyclosporine for Graft-Versus-Host Disease Prophylaxis in Pediatric Patients Undergoing Matched Unrelated Donor Hematopoietic Stem Cell Transplants. A Pediatric Blood and Marrow Transplant Consortium Study. .

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only